Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 6.13093053 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.13093053 |
3 | L-phenylalanine metabolic process (GO:0006558) | 5.94629934 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.94629934 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 5.41520093 |
6 | glyoxylate metabolic process (GO:0046487) | 4.99846792 |
7 | sulfur amino acid catabolic process (GO:0000098) | 4.90477824 |
8 | cysteine metabolic process (GO:0006534) | 4.86094350 |
9 | alpha-linolenic acid metabolic process (GO:0036109) | 4.84397528 |
10 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.79757406 |
11 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.74477140 |
12 | bile acid biosynthetic process (GO:0006699) | 4.73128882 |
13 | indole-containing compound catabolic process (GO:0042436) | 4.69804095 |
14 | indolalkylamine catabolic process (GO:0046218) | 4.69804095 |
15 | tryptophan catabolic process (GO:0006569) | 4.69804095 |
16 | kynurenine metabolic process (GO:0070189) | 4.58340156 |
17 | response to peptidoglycan (GO:0032494) | 4.55662363 |
18 | lysine metabolic process (GO:0006553) | 4.52408464 |
19 | lysine catabolic process (GO:0006554) | 4.52408464 |
20 | protein carboxylation (GO:0018214) | 4.44837724 |
21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.44837724 |
22 | tryptophan metabolic process (GO:0006568) | 4.41754870 |
23 | high-density lipoprotein particle remodeling (GO:0034375) | 4.41154102 |
24 | urea metabolic process (GO:0019627) | 4.31973604 |
25 | urea cycle (GO:0000050) | 4.31973604 |
26 | negative regulation of fibrinolysis (GO:0051918) | 4.30241390 |
27 | regulation of cholesterol esterification (GO:0010872) | 4.19129019 |
28 | serine family amino acid catabolic process (GO:0009071) | 4.17561638 |
29 | amino-acid betaine metabolic process (GO:0006577) | 4.12015205 |
30 | bile acid metabolic process (GO:0008206) | 4.08472632 |
31 | nitrogen cycle metabolic process (GO:0071941) | 3.96687203 |
32 | homocysteine metabolic process (GO:0050667) | 3.94663926 |
33 | serine family amino acid biosynthetic process (GO:0009070) | 3.91691707 |
34 | plasma lipoprotein particle clearance (GO:0034381) | 3.91042226 |
35 | cellular modified amino acid catabolic process (GO:0042219) | 3.89825722 |
36 | regulation of triglyceride catabolic process (GO:0010896) | 3.89768069 |
37 | reverse cholesterol transport (GO:0043691) | 3.89582151 |
38 | protein-lipid complex remodeling (GO:0034368) | 3.87584501 |
39 | macromolecular complex remodeling (GO:0034367) | 3.87584501 |
40 | plasma lipoprotein particle remodeling (GO:0034369) | 3.87584501 |
41 | serine family amino acid metabolic process (GO:0009069) | 3.83157858 |
42 | complement activation, alternative pathway (GO:0006957) | 3.81381683 |
43 | aromatic amino acid family metabolic process (GO:0009072) | 3.80925168 |
44 | regulation of fibrinolysis (GO:0051917) | 3.80100368 |
45 | alpha-amino acid catabolic process (GO:1901606) | 3.74481988 |
46 | phospholipid efflux (GO:0033700) | 3.72519043 |
47 | regulation of cholesterol homeostasis (GO:2000188) | 3.71624664 |
48 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.68886537 |
49 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.68886537 |
50 | modulation by symbiont of host immune response (GO:0052553) | 3.68886537 |
51 | positive regulation by symbiont of host defense response (GO:0052509) | 3.68886537 |
52 | modulation by symbiont of host defense response (GO:0052031) | 3.68886537 |
53 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.68886537 |
54 | fatty acid beta-oxidation (GO:0006635) | 3.67513692 |
55 | barbed-end actin filament capping (GO:0051016) | 3.65867473 |
56 | glycine metabolic process (GO:0006544) | 3.64706436 |
57 | regulation of cholesterol metabolic process (GO:0090181) | 3.64251445 |
58 | 2-oxoglutarate metabolic process (GO:0006103) | 3.63579141 |
59 | cellular glucuronidation (GO:0052695) | 3.63468757 |
60 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.61445295 |
61 | regulation of protein activation cascade (GO:2000257) | 3.61107281 |
62 | phospholipid homeostasis (GO:0055091) | 3.60060262 |
63 | cellular amino acid catabolic process (GO:0009063) | 3.59699977 |
64 | valine metabolic process (GO:0006573) | 3.59284271 |
65 | negative regulation of cholesterol transport (GO:0032375) | 3.58306160 |
66 | negative regulation of sterol transport (GO:0032372) | 3.58306160 |
67 | triglyceride homeostasis (GO:0070328) | 3.52179605 |
68 | acylglycerol homeostasis (GO:0055090) | 3.52179605 |
69 | low-density lipoprotein particle remodeling (GO:0034374) | 3.51167109 |
70 | fatty acid oxidation (GO:0019395) | 3.50121386 |
71 | drug transmembrane transport (GO:0006855) | 3.50081294 |
72 | cholesterol efflux (GO:0033344) | 3.50075826 |
73 | negative regulation of interleukin-12 production (GO:0032695) | 3.48584726 |
74 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.48242181 |
75 | short-chain fatty acid metabolic process (GO:0046459) | 3.47629132 |
76 | aspartate family amino acid catabolic process (GO:0009068) | 3.45986047 |
77 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.45972826 |
78 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.45972826 |
79 | lipid oxidation (GO:0034440) | 3.44646437 |
80 | tyrosine metabolic process (GO:0006570) | 3.44590958 |
81 | acetyl-CoA metabolic process (GO:0006084) | 3.40928048 |
82 | monocarboxylic acid catabolic process (GO:0072329) | 3.36111617 |
83 | regulation of complement activation (GO:0030449) | 3.36017729 |
84 | fatty acid catabolic process (GO:0009062) | 3.35573695 |
85 | carnitine metabolic process (GO:0009437) | 3.35192223 |
86 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.33426592 |
87 | NIK/NF-kappaB signaling (GO:0038061) | 3.32704434 |
88 | cellular ketone body metabolic process (GO:0046950) | 3.32495068 |
89 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.32166599 |
90 | negative regulation of cell killing (GO:0031342) | 3.32166599 |
91 | carboxylic acid catabolic process (GO:0046395) | 3.31315607 |
92 | organic acid catabolic process (GO:0016054) | 3.31315607 |
93 | cholesterol homeostasis (GO:0042632) | 3.31037337 |
94 | plasma lipoprotein particle assembly (GO:0034377) | 3.29451881 |
95 | response to mercury ion (GO:0046689) | 3.28877774 |
96 | glucuronate metabolic process (GO:0019585) | 3.28625643 |
97 | uronic acid metabolic process (GO:0006063) | 3.28625643 |
98 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.27813666 |
99 | macrophage activation involved in immune response (GO:0002281) | 3.27774763 |
100 | sterol homeostasis (GO:0055092) | 3.27460592 |
101 | coenzyme catabolic process (GO:0009109) | 3.27361169 |
102 | urate metabolic process (GO:0046415) | 3.26581340 |
103 | protein-lipid complex assembly (GO:0065005) | 3.25288502 |
104 | cellular biogenic amine catabolic process (GO:0042402) | 3.25174869 |
105 | amine catabolic process (GO:0009310) | 3.25174869 |
106 | glutamate metabolic process (GO:0006536) | 3.25071544 |
107 | bile acid and bile salt transport (GO:0015721) | 3.24302346 |
108 | ethanol oxidation (GO:0006069) | 3.24240152 |
109 | neutrophil activation involved in immune response (GO:0002283) | 3.23792649 |
110 | intestinal cholesterol absorption (GO:0030299) | 3.22709392 |
111 | drug catabolic process (GO:0042737) | 3.21514983 |
112 | lipoprotein metabolic process (GO:0042157) | 3.20941455 |
113 | response to nitrosative stress (GO:0051409) | 3.20004149 |
114 | positive regulation of lipid catabolic process (GO:0050996) | 3.19209538 |
115 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.18137174 |
116 | immunoglobulin mediated immune response (GO:0016064) | 3.14855311 |
117 | benzene-containing compound metabolic process (GO:0042537) | 3.14011808 |
118 | pyrimidine nucleoside salvage (GO:0043097) | 3.12253401 |
119 | pyrimidine-containing compound salvage (GO:0008655) | 3.12253401 |
120 | response to muramyl dipeptide (GO:0032495) | 3.08732649 |
121 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.07468915 |
122 | detection of molecule of bacterial origin (GO:0032490) | 3.07128805 |
123 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.05162433 |
124 | detection of other organism (GO:0098543) | 3.04596306 |
125 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.00426971 |
126 | pinocytosis (GO:0006907) | 2.98175399 |
127 | cellular extravasation (GO:0045123) | 2.96705932 |
128 | glycosphingolipid catabolic process (GO:0046479) | 2.95453106 |
129 | protein localization to endosome (GO:0036010) | 2.94551411 |
130 | mannose metabolic process (GO:0006013) | 2.93154876 |
131 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.91741337 |
132 | detection of bacterium (GO:0016045) | 2.88979440 |
133 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.87403633 |
134 | detection of external biotic stimulus (GO:0098581) | 2.86074572 |
135 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.81368108 |
136 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.80779573 |
137 | regulation of leukocyte degranulation (GO:0043300) | 2.79755946 |
138 | response to type I interferon (GO:0034340) | 2.79428132 |
139 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.78481762 |
140 | cellular response to type I interferon (GO:0071357) | 2.77311734 |
141 | type I interferon signaling pathway (GO:0060337) | 2.77311734 |
142 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.77014768 |
143 | glycolipid catabolic process (GO:0019377) | 2.74814348 |
144 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.71081300 |
145 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.69538753 |
146 | stress fiber assembly (GO:0043149) | 2.69288734 |
147 | regulation of mast cell degranulation (GO:0043304) | 2.68642598 |
148 | germinal center formation (GO:0002467) | 2.67734722 |
149 | low-density lipoprotein particle clearance (GO:0034383) | 2.66263616 |
150 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.65237338 |
151 | Golgi transport vesicle coating (GO:0048200) | 2.64053671 |
152 | COPI coating of Golgi vesicle (GO:0048205) | 2.64053671 |
153 | oligosaccharide catabolic process (GO:0009313) | 2.63022103 |
154 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.61750988 |
155 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.60837244 |
156 | regulation of necrotic cell death (GO:0010939) | 2.60096559 |
157 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.58548072 |
158 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.57757144 |
159 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.57421233 |
160 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.57273740 |
161 | regulation of necroptotic process (GO:0060544) | 2.56274447 |
162 | amino sugar catabolic process (GO:0046348) | 2.55060742 |
163 | modulation by symbiont of host cellular process (GO:0044068) | 2.54135446 |
164 | response to host defenses (GO:0052200) | 2.53868160 |
165 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.53868160 |
166 | response to host (GO:0075136) | 2.53868160 |
167 | response to laminar fluid shear stress (GO:0034616) | 2.52355343 |
168 | macrophage activation (GO:0042116) | 2.52158026 |
169 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.49012968 |
170 | regulation of superoxide anion generation (GO:0032928) | 2.48716058 |
171 | response to host immune response (GO:0052572) | 2.48660502 |
172 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.48660502 |
173 | N-acetylneuraminate metabolic process (GO:0006054) | 2.46355050 |
174 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.44585500 |
175 | cellular response to arsenic-containing substance (GO:0071243) | 2.44335004 |
176 | positive regulation of macrophage differentiation (GO:0045651) | 2.44129806 |
177 | granulocyte activation (GO:0036230) | 2.42481068 |
178 | detection of biotic stimulus (GO:0009595) | 2.42323411 |
179 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.42205044 |
180 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.41756507 |
181 | negative regulation of innate immune response (GO:0045824) | 2.40784050 |
182 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.40391943 |
183 | response to progesterone (GO:0032570) | 2.39541174 |
184 | interferon-gamma secretion (GO:0072643) | 2.38613122 |
185 | regulation of chemokine biosynthetic process (GO:0045073) | 2.38576301 |
186 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.37321629 |
187 | myeloid cell activation involved in immune response (GO:0002275) | 2.36464017 |
188 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.36435521 |
189 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.36063176 |
190 | mature B cell differentiation involved in immune response (GO:0002313) | 2.35725201 |
191 | myeloid dendritic cell differentiation (GO:0043011) | 2.35247931 |
192 | response to thyroid hormone (GO:0097066) | 2.34626751 |
193 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.34236416 |
194 | pentose-phosphate shunt (GO:0006098) | 2.34176785 |
195 | GDP-mannose metabolic process (GO:0019673) | 2.34099583 |
196 | regulation of tumor necrosis factor production (GO:0032680) | 2.33341751 |
197 | hyaluronan catabolic process (GO:0030214) | 2.33023532 |
198 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.32808641 |
199 | regulation of vitamin metabolic process (GO:0030656) | 2.32307166 |
200 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.31773425 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.72374637 |
2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.29917966 |
3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.71761841 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.10193092 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.34202173 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.31369058 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.13311033 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.76995988 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.13007811 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.96714768 |
11 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.96292403 |
12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.58662812 |
13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.22583136 |
14 | * VDR_24763502_ChIP-Seq_THP-1_Human | 2.20153163 |
15 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.05355078 |
16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.98855380 |
17 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.95600687 |
18 | * MYC_22102868_ChIP-Seq_BL_Human | 1.94537864 |
19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.94437226 |
20 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.92020149 |
21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.88355660 |
22 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.82122788 |
23 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.77722399 |
24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.76408665 |
25 | * TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.73432809 |
26 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.67339254 |
27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.65690174 |
28 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.63508330 |
29 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.62026499 |
30 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.59407633 |
31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56484397 |
32 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.52449968 |
33 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.51232905 |
34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.49201911 |
35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49120627 |
36 | UTX_26944678_Chip-Seq_JUKART_Human | 1.46878780 |
37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.43697970 |
38 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.43677392 |
39 | MAF_26560356_Chip-Seq_TH2_Human | 1.41408318 |
40 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.41368194 |
41 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.40303297 |
42 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.38790922 |
43 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.37902516 |
44 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.33839911 |
45 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32653408 |
46 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31374295 |
47 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30884609 |
48 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.29840752 |
49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29693158 |
50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.28507518 |
51 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.27778337 |
52 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.26925050 |
53 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26487979 |
54 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.26445353 |
55 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.23261413 |
56 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22606035 |
57 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.22178285 |
58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21846789 |
59 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21692139 |
60 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19158048 |
61 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.18996488 |
62 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.18899635 |
63 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.18500891 |
64 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.17631173 |
65 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17250182 |
66 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.17143228 |
67 | P68_20966046_ChIP-Seq_HELA_Human | 1.16951434 |
68 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.15895334 |
69 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.13296862 |
70 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.13259299 |
71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.12488629 |
72 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.12153822 |
73 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.11889336 |
74 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.09421925 |
75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08903689 |
76 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.07812393 |
77 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.07772404 |
78 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06859838 |
79 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.06612264 |
80 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.06355318 |
81 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06220918 |
82 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05455577 |
83 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.03787804 |
84 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.03218311 |
85 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.03126848 |
86 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.02120856 |
87 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01906389 |
88 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01906389 |
89 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.01782046 |
90 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01666518 |
91 | GATA2_19941826_ChIP-Seq_K562_Human | 1.01518677 |
92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01422708 |
93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.00843302 |
94 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.00130900 |
95 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99731276 |
96 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.98824850 |
97 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.98619481 |
98 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97677189 |
99 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96797888 |
100 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.96340070 |
101 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96278125 |
102 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.96066710 |
103 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.96023807 |
104 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95669038 |
105 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94148606 |
106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.92184001 |
107 | ATF3_27146783_Chip-Seq_COLON_Human | 0.92110336 |
108 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91243159 |
109 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.89727583 |
110 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.89340829 |
111 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.88203725 |
112 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.87764002 |
113 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87138123 |
114 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85716108 |
115 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.84721967 |
116 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.84399520 |
117 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.80286923 |
118 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79384901 |
119 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.79287126 |
120 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.79101964 |
121 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78710561 |
122 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.77446654 |
123 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.77326283 |
124 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.77199047 |
125 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76195138 |
126 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.76020913 |
127 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75660504 |
128 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.75492206 |
129 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.75386758 |
130 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.75076105 |
131 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.74790235 |
132 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74304374 |
133 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.73571087 |
134 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.72055743 |
135 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.71781427 |
136 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.71495621 |
137 | MAF_26560356_Chip-Seq_TH1_Human | 0.71210027 |
138 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.71017025 |
139 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.70153162 |
140 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.69777440 |
141 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.69086393 |
142 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68822816 |
143 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.68085759 |
144 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67874326 |
145 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.67627584 |
146 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.67359891 |
147 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.67075547 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 6.77182405 |
2 | MP0005360_urolithiasis | 6.31055289 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.64791721 |
4 | MP0005365_abnormal_bile_salt | 4.55457860 |
5 | MP0009840_abnormal_foam_cell | 3.67498010 |
6 | MP0003806_abnormal_nucleotide_metabolis | 3.66923238 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.58777089 |
8 | MP0003252_abnormal_bile_duct | 3.10261174 |
9 | MP0003303_peritoneal_inflammation | 2.96612019 |
10 | MP0010329_abnormal_lipoprotein_level | 2.74870604 |
11 | MP0003195_calcinosis | 2.67017452 |
12 | MP0005332_abnormal_amino_acid | 2.66882872 |
13 | MP0005083_abnormal_biliary_tract | 2.35313452 |
14 | MP0001666_abnormal_nutrient_absorption | 2.33825235 |
15 | MP0003724_increased_susceptibility_to | 2.29256123 |
16 | MP0003191_abnormal_cellular_cholesterol | 2.22182196 |
17 | MP0008260_abnormal_autophagy | 2.17952546 |
18 | MP0001835_abnormal_antigen_presentation | 2.16151499 |
19 | MP0003172_abnormal_lysosome_physiology | 2.15127401 |
20 | MP0004510_myositis | 2.09111581 |
21 | MP0003705_abnormal_hypodermis_morpholog | 2.04767582 |
22 | MP0002148_abnormal_hypersensitivity_rea | 2.00769485 |
23 | MP0005025_abnormal_response_to | 1.99071673 |
24 | MP0009785_altered_susceptibility_to | 1.98138190 |
25 | MP0000685_abnormal_immune_system | 1.96038501 |
26 | MP0002118_abnormal_lipid_homeostasis | 1.88223224 |
27 | MP0000609_abnormal_liver_physiology | 1.87914140 |
28 | MP0004019_abnormal_vitamin_homeostasis | 1.84864828 |
29 | MP0005000_abnormal_immune_tolerance | 1.84297127 |
30 | MP0001533_abnormal_skeleton_physiology | 1.79585385 |
31 | MP0003656_abnormal_erythrocyte_physiolo | 1.79154126 |
32 | MP0005319_abnormal_enzyme/_coenzyme | 1.77176856 |
33 | MP0001790_abnormal_immune_system | 1.74080787 |
34 | MP0005387_immune_system_phenotype | 1.74080787 |
35 | MP0003186_abnormal_redox_activity | 1.65298239 |
36 | MP0002452_abnormal_antigen_presenting | 1.60761829 |
37 | MP0009643_abnormal_urine_homeostasis | 1.60525967 |
38 | MP0000858_altered_metastatic_potential | 1.59692935 |
39 | MP0005451_abnormal_body_composition | 1.57227864 |
40 | MP0003828_pulmonary_edema | 1.55732089 |
41 | MP0002723_abnormal_immune_serum | 1.54810981 |
42 | MP0002138_abnormal_hepatobiliary_system | 1.54433068 |
43 | MP0005670_abnormal_white_adipose | 1.53612274 |
44 | MP0005058_abnormal_lysosome_morphology | 1.51187214 |
45 | MP0005076_abnormal_cell_differentiation | 1.51158170 |
46 | MP0009278_abnormal_bone_marrow | 1.48524492 |
47 | MP0001764_abnormal_homeostasis | 1.47376407 |
48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.47204033 |
49 | MP0002420_abnormal_adaptive_immunity | 1.45383631 |
50 | MP0002998_abnormal_bone_remodeling | 1.44671300 |
51 | MP0001819_abnormal_immune_cell | 1.44519500 |
52 | MP0008438_abnormal_cutaneous_collagen | 1.44136259 |
53 | MP0000343_altered_response_to | 1.43778373 |
54 | MP0001800_abnormal_humoral_immune | 1.43743871 |
55 | MP0002405_respiratory_system_inflammati | 1.43036582 |
56 | MP0005671_abnormal_response_to | 1.32936552 |
57 | MP0003091_abnormal_cell_migration | 1.32582817 |
58 | MP0009333_abnormal_splenocyte_physiolog | 1.28780245 |
59 | MP0004233_abnormal_muscle_weight | 1.28088561 |
60 | MP0002837_dystrophic_cardiac_calcinosis | 1.24470421 |
61 | MP0003868_abnormal_feces_composition | 1.23015199 |
62 | MP0004130_abnormal_muscle_cell | 1.20458969 |
63 | MP0003763_abnormal_thymus_physiology | 1.18137324 |
64 | MP0000598_abnormal_liver_morphology | 1.17979348 |
65 | MP0004043_abnormal_pH_regulation | 1.16436957 |
66 | MP0001853_heart_inflammation | 1.14651411 |
67 | MP0001849_ear_inflammation | 1.14254341 |
68 | MP0000716_abnormal_immune_system | 1.10030273 |
69 | MP0002796_impaired_skin_barrier | 1.07045209 |
70 | MP0005666_abnormal_adipose_tissue | 1.05964812 |
71 | MP0000749_muscle_degeneration | 1.05730274 |
72 | MP0010234_abnormal_vibrissa_follicle | 1.03752984 |
73 | MP0002398_abnormal_bone_marrow | 1.02862676 |
74 | MP0001542_abnormal_bone_strength | 1.02348892 |
75 | MP0000750_abnormal_muscle_regeneration | 1.02290845 |
76 | MP0005390_skeleton_phenotype | 1.01717494 |
77 | MP0003329_amyloid_beta_deposits | 1.00470377 |
78 | MP0004808_abnormal_hematopoietic_stem | 0.99961426 |
79 | MP0005164_abnormal_response_to | 0.98985156 |
80 | MP0002269_muscular_atrophy | 0.98891609 |
81 | MP0006036_abnormal_mitochondrial_physio | 0.98405891 |
82 | MP0003448_altered_tumor_morphology | 0.98404263 |
83 | MP0005636_abnormal_mineral_homeostasis | 0.98396629 |
84 | MP0005397_hematopoietic_system_phenotyp | 0.98225636 |
85 | MP0001545_abnormal_hematopoietic_system | 0.98225636 |
86 | MP0008469_abnormal_protein_level | 0.97436874 |
87 | MP0002722_abnormal_immune_system | 0.95539142 |
88 | MP0005408_hypopigmentation | 0.95244168 |
89 | MP0002332_abnormal_exercise_endurance | 0.94993393 |
90 | MP0005310_abnormal_salivary_gland | 0.94427749 |
91 | MP0002429_abnormal_blood_cell | 0.93705146 |
92 | MP0005165_increased_susceptibility_to | 0.92659371 |
93 | MP0001756_abnormal_urination | 0.89544367 |
94 | MP0001216_abnormal_epidermal_layer | 0.88960820 |
95 | MP0005501_abnormal_skin_physiology | 0.87357049 |
96 | MP0000604_amyloidosis | 0.87230596 |
97 | MP0009764_decreased_sensitivity_to | 0.86121999 |
98 | MP0005647_abnormal_sex_gland | 0.86061306 |
99 | MP0004858_abnormal_nervous_system | 0.85816319 |
100 | MP0002078_abnormal_glucose_homeostasis | 0.85627329 |
101 | MP0001958_emphysema | 0.85452441 |
102 | MP0000689_abnormal_spleen_morphology | 0.85310861 |
103 | MP0003795_abnormal_bone_structure | 0.85229198 |
104 | MP0003436_decreased_susceptibility_to | 0.83954286 |
105 | MP0003011_delayed_dark_adaptation | 0.83163897 |
106 | MP0000678_abnormal_parathyroid_gland | 0.82331874 |
107 | MP0000733_abnormal_muscle_development | 0.81795090 |
108 | MP0009642_abnormal_blood_homeostasis | 0.81761953 |
109 | MP0001851_eye_inflammation | 0.81749771 |
110 | MP0002136_abnormal_kidney_physiology | 0.81123380 |
111 | MP0003300_gastrointestinal_ulcer | 0.80279776 |
112 | MP0009763_increased_sensitivity_to | 0.80261693 |
113 | MP0003183_abnormal_peptide_metabolism | 0.79783937 |
114 | MP0000703_abnormal_thymus_morphology | 0.78189152 |
115 | MP0000465_gastrointestinal_hemorrhage | 0.78036591 |
116 | MP0002971_abnormal_brown_adipose | 0.77667459 |
117 | MP0005330_cardiomyopathy | 0.77416755 |
118 | MP0003075_altered_response_to | 0.76722873 |
119 | MP0000747_muscle_weakness | 0.76573075 |
120 | MP0005220_abnormal_exocrine_pancreas | 0.76045785 |
121 | MP0003690_abnormal_glial_cell | 0.75698480 |
122 | MP0005334_abnormal_fat_pad | 0.75561272 |
123 | MP0010368_abnormal_lymphatic_system | 0.75536495 |
124 | MP0006082_CNS_inflammation | 0.74738535 |
125 | MP0005375_adipose_tissue_phenotype | 0.73956314 |
126 | MP0005464_abnormal_platelet_physiology | 0.73893279 |
127 | MP0002166_altered_tumor_susceptibility | 0.73563388 |
128 | MP0002396_abnormal_hematopoietic_system | 0.73314022 |
129 | MP0004782_abnormal_surfactant_physiolog | 0.72278304 |
130 | MP0002132_abnormal_respiratory_system | 0.70408777 |
131 | MP0002060_abnormal_skin_morphology | 0.69797286 |
132 | MP0001873_stomach_inflammation | 0.69339176 |
133 | MP0005376_homeostasis/metabolism_phenot | 0.69286378 |
134 | MP0003646_muscle_fatigue | 0.68699989 |
135 | MP0003453_abnormal_keratinocyte_physiol | 0.68660827 |
136 | MP0002877_abnormal_melanocyte_morpholog | 0.68477557 |
137 | MP0004087_abnormal_muscle_fiber | 0.68256782 |
138 | MP0003566_abnormal_cell_adhesion | 0.67957566 |
139 | MP0004185_abnormal_adipocyte_glucose | 0.67288998 |
140 | MP0005023_abnormal_wound_healing | 0.61988359 |
141 | MP0001765_abnormal_ion_homeostasis | 0.59702706 |
142 | MP0009115_abnormal_fat_cell | 0.59549040 |
143 | MP0004036_abnormal_muscle_relaxation | 0.58068184 |
144 | MP0002254_reproductive_system_inflammat | 0.56322328 |
145 | MP0005266_abnormal_metabolism | 0.56291282 |
146 | MP0005084_abnormal_gallbladder_morpholo | 0.54740110 |
147 | MP0006054_spinal_hemorrhage | 0.54344143 |
148 | MP0003279_aneurysm | 0.53903929 |
149 | MP0002928_abnormal_bile_duct | 0.53641514 |
150 | MP0001243_abnormal_dermal_layer | 0.53275258 |
151 | MP0009053_abnormal_anal_canal | 0.53164398 |
152 | MP0009765_abnormal_xenobiotic_induced | 0.52405659 |
153 | MP0010630_abnormal_cardiac_muscle | 0.52238267 |
154 | MP0004947_skin_inflammation | 0.51725956 |
155 | MP0009384_cardiac_valve_regurgitation | 0.50883516 |
156 | MP0001845_abnormal_inflammatory_respons | 0.50875986 |
157 | MP0005448_abnormal_energy_balance | 0.48187529 |
158 | MP0002168_other_aberrant_phenotype | 0.47649298 |
159 | MP0005166_decreased_susceptibility_to | 0.46838282 |
160 | MP0005535_abnormal_body_temperature | 0.44681619 |
161 | MP0001544_abnormal_cardiovascular_syste | 0.44573201 |
162 | MP0005385_cardiovascular_system_phenoty | 0.44573201 |
163 | MP0000249_abnormal_blood_vessel | 0.44305231 |
164 | MP0010155_abnormal_intestine_physiology | 0.43654462 |
165 | MP0002135_abnormal_kidney_morphology | 0.43318931 |
166 | MP0002876_abnormal_thyroid_physiology | 0.42950118 |
167 | MP0002419_abnormal_innate_immunity | 0.42419563 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Intrahepatic cholestasis (HP:0001406) | 5.67978794 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.63653122 |
3 | Xanthomatosis (HP:0000991) | 5.23616340 |
4 | Deep venous thrombosis (HP:0002625) | 5.18410452 |
5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.03410607 |
6 | Abnormality of glycolipid metabolism (HP:0010969) | 4.74756057 |
7 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.74756057 |
8 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.74756057 |
9 | Hypobetalipoproteinemia (HP:0003563) | 4.28759677 |
10 | Prolonged partial thromboplastin time (HP:0003645) | 4.18838170 |
11 | Hyperglycinuria (HP:0003108) | 4.15694607 |
12 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.92940711 |
13 | Eczematoid dermatitis (HP:0000976) | 3.90324312 |
14 | Hyperlipoproteinemia (HP:0010980) | 3.88776289 |
15 | Hyperammonemia (HP:0001987) | 3.86959177 |
16 | Ketosis (HP:0001946) | 3.82794048 |
17 | Hypoglycemic coma (HP:0001325) | 3.82719174 |
18 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.81279017 |
19 | Abnormality of glycine metabolism (HP:0010895) | 3.81279017 |
20 | Recurrent abscess formation (HP:0002722) | 3.73932725 |
21 | Dysostosis multiplex (HP:0000943) | 3.67774788 |
22 | Recurrent bacterial skin infections (HP:0005406) | 3.66051039 |
23 | Complement deficiency (HP:0004431) | 3.65827349 |
24 | Abnormality of macrophages (HP:0004311) | 3.65240909 |
25 | Hyperglycinemia (HP:0002154) | 3.63356535 |
26 | Joint hemorrhage (HP:0005261) | 3.57538017 |
27 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.53320206 |
28 | Hypolipoproteinemia (HP:0010981) | 3.50113626 |
29 | Fat malabsorption (HP:0002630) | 3.48367799 |
30 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.45305646 |
31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.34523816 |
32 | Hypoalphalipoproteinemia (HP:0003233) | 3.28963965 |
33 | Abnormality of the common coagulation pathway (HP:0010990) | 3.24133258 |
34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.22322447 |
35 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.22263720 |
36 | Ketoacidosis (HP:0001993) | 3.22177911 |
37 | Epidermoid cyst (HP:0200040) | 3.14336133 |
38 | Vertebral compression fractures (HP:0002953) | 3.13818034 |
39 | Loss of speech (HP:0002371) | 3.11590949 |
40 | Myocardial infarction (HP:0001658) | 3.10923468 |
41 | Abnormality of the intrinsic pathway (HP:0010989) | 3.09618931 |
42 | Gout (HP:0001997) | 3.07680069 |
43 | Increased cerebral lipofuscin (HP:0011813) | 3.07358337 |
44 | Abnormality of purine metabolism (HP:0004352) | 2.97152745 |
45 | Hyperbilirubinemia (HP:0002904) | 2.96847689 |
46 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.92314672 |
47 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.92314672 |
48 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.92314672 |
49 | Abnormality of methionine metabolism (HP:0010901) | 2.90724828 |
50 | Mucopolysacchariduria (HP:0008155) | 2.87612590 |
51 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.87612590 |
52 | Abnormality of complement system (HP:0005339) | 2.83917821 |
53 | Abnormality of nucleobase metabolism (HP:0010932) | 2.78588266 |
54 | Abnormal gallbladder morphology (HP:0012437) | 2.76719010 |
55 | Hypercholesterolemia (HP:0003124) | 2.76353151 |
56 | Increased serum ferritin (HP:0003281) | 2.74513934 |
57 | Vacuolated lymphocytes (HP:0001922) | 2.74344789 |
58 | Vascular calcification (HP:0004934) | 2.70978623 |
59 | Late onset (HP:0003584) | 2.70463464 |
60 | Steatorrhea (HP:0002570) | 2.67396031 |
61 | Cholelithiasis (HP:0001081) | 2.66738290 |
62 | Myositis (HP:0100614) | 2.64510411 |
63 | Dicarboxylic aciduria (HP:0003215) | 2.59043494 |
64 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59043494 |
65 | Conjugated hyperbilirubinemia (HP:0002908) | 2.58737989 |
66 | Interstitial pulmonary disease (HP:0006530) | 2.56466548 |
67 | Orchitis (HP:0100796) | 2.55193534 |
68 | Generalized aminoaciduria (HP:0002909) | 2.55009589 |
69 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.54713416 |
70 | Cardiovascular calcification (HP:0011915) | 2.51505477 |
71 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.47444476 |
72 | Hepatocellular carcinoma (HP:0001402) | 2.47172129 |
73 | Metabolic acidosis (HP:0001942) | 2.46684576 |
74 | Hypoglycemic seizures (HP:0002173) | 2.45975125 |
75 | Mitral stenosis (HP:0001718) | 2.42994093 |
76 | Gingivitis (HP:0000230) | 2.42082086 |
77 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.41459307 |
78 | Distal lower limb muscle weakness (HP:0009053) | 2.40891222 |
79 | Increased IgE level (HP:0003212) | 2.40028972 |
80 | Myoglobinuria (HP:0002913) | 2.39220153 |
81 | Mediastinal lymphadenopathy (HP:0100721) | 2.36883286 |
82 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.36880100 |
83 | Abnormality of proline metabolism (HP:0010907) | 2.35601597 |
84 | Hydroxyprolinuria (HP:0003080) | 2.35601597 |
85 | Cellulitis (HP:0100658) | 2.35408492 |
86 | Systemic lupus erythematosus (HP:0002725) | 2.32972610 |
87 | Amyloidosis (HP:0011034) | 2.31296846 |
88 | Abnormality of serum amino acid levels (HP:0003112) | 2.30184741 |
89 | Recurrent skin infections (HP:0001581) | 2.30131007 |
90 | Slow saccadic eye movements (HP:0000514) | 2.28719254 |
91 | Increased connective tissue (HP:0009025) | 2.28119910 |
92 | Exercise-induced muscle cramps (HP:0003710) | 2.27886291 |
93 | Skin nodule (HP:0200036) | 2.27545018 |
94 | Sensorimotor neuropathy (HP:0007141) | 2.25006592 |
95 | Abnormality of the gallbladder (HP:0005264) | 2.19563369 |
96 | Ragged-red muscle fibers (HP:0003200) | 2.18399042 |
97 | Axonal loss (HP:0003447) | 2.18365462 |
98 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.16400021 |
99 | Increased purine levels (HP:0004368) | 2.15617435 |
100 | Hyperuricemia (HP:0002149) | 2.15617435 |
101 | Acanthocytosis (HP:0001927) | 2.13493784 |
102 | Malnutrition (HP:0004395) | 2.13272776 |
103 | Hepatosplenomegaly (HP:0001433) | 2.11231795 |
104 | Petechiae (HP:0000967) | 2.08166408 |
105 | Cervical subluxation (HP:0003308) | 2.07851422 |
106 | Lethargy (HP:0001254) | 2.07214059 |
107 | Irritability (HP:0000737) | 2.06483722 |
108 | Proximal tubulopathy (HP:0000114) | 2.06442545 |
109 | Recurrent fungal infections (HP:0002841) | 2.05537283 |
110 | Obstructive lung disease (HP:0006536) | 2.03592924 |
111 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03592924 |
112 | Reticulocytosis (HP:0001923) | 2.02993312 |
113 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.02958011 |
114 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.01547715 |
115 | Colitis (HP:0002583) | 2.01541012 |
116 | Distal lower limb amyotrophy (HP:0008944) | 2.01431653 |
117 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.00303622 |
118 | Osteolytic defects of the hand bones (HP:0009699) | 2.00303622 |
119 | Opisthotonus (HP:0002179) | 1.98684342 |
120 | Esophageal varix (HP:0002040) | 1.97951174 |
121 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.97324205 |
122 | Rough bone trabeculation (HP:0100670) | 1.96170365 |
123 | Delayed CNS myelination (HP:0002188) | 1.95213316 |
124 | Pancreatitis (HP:0001733) | 1.94401383 |
125 | Thin bony cortex (HP:0002753) | 1.94335276 |
126 | Abnormal gallbladder physiology (HP:0012438) | 1.93069709 |
127 | Cholecystitis (HP:0001082) | 1.93069709 |
128 | Gingival bleeding (HP:0000225) | 1.92934404 |
129 | Progressive muscle weakness (HP:0003323) | 1.92647369 |
130 | Prolonged neonatal jaundice (HP:0006579) | 1.92618484 |
131 | Poikilocytosis (HP:0004447) | 1.92391935 |
132 | Protrusio acetabuli (HP:0003179) | 1.91176366 |
133 | Nuclear cataract (HP:0100018) | 1.88902293 |
134 | Short nail (HP:0001799) | 1.88310105 |
135 | Premature rupture of membranes (HP:0001788) | 1.87940337 |
136 | Right ventricular cardiomyopathy (HP:0011663) | 1.87815739 |
137 | Lower limb hyperreflexia (HP:0002395) | 1.86641740 |
138 | Urticaria (HP:0001025) | 1.86082069 |
139 | Spondylolisthesis (HP:0003302) | 1.85921928 |
140 | Hemorrhage of the eye (HP:0011885) | 1.84484108 |
141 | Polycythemia (HP:0001901) | 1.84186914 |
142 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.84059684 |
143 | Abnormality of iron homeostasis (HP:0011031) | 1.83977801 |
144 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.83865106 |
145 | Joint stiffness (HP:0001387) | 1.83094705 |
146 | Spontaneous abortion (HP:0005268) | 1.81750571 |
147 | Vomiting (HP:0002013) | 1.81338437 |
148 | Symptomatic seizures (HP:0011145) | 1.81070449 |
149 | Generalized amyotrophy (HP:0003700) | 1.80994713 |
150 | Elevated alkaline phosphatase (HP:0003155) | 1.80928527 |
151 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.80718969 |
152 | Hyperglycemia (HP:0003074) | 1.80476184 |
153 | Achilles tendon contracture (HP:0001771) | 1.80116042 |
154 | Alkalosis (HP:0001948) | 1.79830107 |
155 | Ileus (HP:0002595) | 1.79770033 |
156 | Glycosuria (HP:0003076) | 1.79685094 |
157 | Abnormality of urine glucose concentration (HP:0011016) | 1.79685094 |
158 | Asymmetric septal hypertrophy (HP:0001670) | 1.79471298 |
159 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.78894520 |
160 | Hypertensive crisis (HP:0100735) | 1.77766127 |
161 | Purpura (HP:0000979) | 1.76773061 |
162 | Neuronal loss in central nervous system (HP:0002529) | 1.75298786 |
163 | Gastrointestinal inflammation (HP:0004386) | 1.74765500 |
164 | Pathologic fracture (HP:0002756) | 1.74466183 |
165 | Optic neuritis (HP:0100653) | 1.74101821 |
166 | Retrobulbar optic neuritis (HP:0100654) | 1.74101821 |
167 | Progressive neurologic deterioration (HP:0002344) | 1.73182708 |
168 | Broad face (HP:0000283) | 1.72614368 |
169 | Polygenic inheritance (HP:0010982) | 1.70659637 |
170 | Autoimmune thrombocytopenia (HP:0001973) | 1.69045993 |
171 | Bulbar palsy (HP:0001283) | 1.68759988 |
172 | Stomatitis (HP:0010280) | 1.68243564 |
173 | Recurrent cutaneous fungal infections (HP:0011370) | 1.67591387 |
174 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.67591387 |
175 | Thick nail (HP:0001805) | 1.67572176 |
176 | Inflammation of the large intestine (HP:0002037) | 1.66140576 |
177 | Thoracic kyphosis (HP:0002942) | 1.63890079 |
178 | Bone pain (HP:0002653) | 1.63837400 |
179 | J-shaped sella turcica (HP:0002680) | 1.61944197 |
180 | Hypertriglyceridemia (HP:0002155) | 1.61487681 |
181 | Abnormality of the Achilles tendon (HP:0005109) | 1.61484507 |
182 | Cheilitis (HP:0100825) | 1.61277435 |
183 | Recurrent viral infections (HP:0004429) | 1.61091613 |
184 | Abnormal trabecular bone morphology (HP:0100671) | 1.60755314 |
185 | Upper motor neuron abnormality (HP:0002127) | 1.60402446 |
186 | Pustule (HP:0200039) | 1.59672013 |
187 | Difficulty climbing stairs (HP:0003551) | 1.59607946 |
188 | Cerebral inclusion bodies (HP:0100314) | 1.59219458 |
189 | Meningitis (HP:0001287) | 1.58699316 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BCKDK | 4.63980336 |
2 | ERN1 | 4.22538094 |
3 | TRIB3 | 3.42992458 |
4 | SIK1 | 3.35766018 |
5 | NME2 | 2.72008298 |
6 | PKN2 | 2.42653284 |
7 | TESK2 | 2.26159161 |
8 | SMG1 | 2.13213854 |
9 | RIPK4 | 2.08360087 |
10 | EPHB1 | 2.04575364 |
11 | PRPF4B | 2.00463335 |
12 | BLK | 1.92285211 |
13 | TTN | 1.91937771 |
14 | FGFR4 | 1.85416534 |
15 | TAOK2 | 1.79212892 |
16 | AKT3 | 1.74755435 |
17 | TBK1 | 1.68258995 |
18 | TESK1 | 1.65716500 |
19 | PTK6 | 1.65005375 |
20 | TAOK3 | 1.57867604 |
21 | WNK4 | 1.57435098 |
22 | TRPM7 | 1.55571956 |
23 | MAP3K14 | 1.55387865 |
24 | IRAK3 | 1.45054305 |
25 | MAP3K1 | 1.43550686 |
26 | NEK9 | 1.38791701 |
27 | TYK2 | 1.38130776 |
28 | MAP3K10 | 1.36322548 |
29 | LATS1 | 1.35600415 |
30 | BMX | 1.34886315 |
31 | TAOK1 | 1.34573405 |
32 | TLK1 | 1.34031761 |
33 | PINK1 | 1.32257468 |
34 | ICK | 1.30318190 |
35 | MAPK11 | 1.29923217 |
36 | FLT3 | 1.29315680 |
37 | IRAK4 | 1.27931457 |
38 | ARAF | 1.26890558 |
39 | PIK3CG | 1.24994488 |
40 | MAP3K3 | 1.24557597 |
41 | OBSCN | 1.23343892 |
42 | PAK4 | 1.20920977 |
43 | INSRR | 1.17349842 |
44 | FRK | 1.16710247 |
45 | STK39 | 1.14446504 |
46 | PIM1 | 1.11885086 |
47 | IKBKE | 1.09120681 |
48 | STK38L | 1.07643705 |
49 | EEF2K | 1.06894612 |
50 | ERBB4 | 1.06204914 |
51 | MAPK15 | 1.04065609 |
52 | MAP3K13 | 1.01174054 |
53 | MET | 1.00275627 |
54 | MAP2K3 | 0.98532581 |
55 | CDC42BPA | 0.98193252 |
56 | EPHA2 | 0.98018695 |
57 | STK4 | 0.96420427 |
58 | JAK1 | 0.92201031 |
59 | GSK3A | 0.88596779 |
60 | TGFBR2 | 0.88266900 |
61 | SGK3 | 0.87548210 |
62 | DYRK1B | 0.86541609 |
63 | MST1R | 0.85530861 |
64 | JAK2 | 0.85185903 |
65 | PDK3 | 0.84171628 |
66 | PDK4 | 0.84171628 |
67 | PDK2 | 0.84073171 |
68 | MOS | 0.81774770 |
69 | CHUK | 0.80564978 |
70 | PRKAA2 | 0.79981640 |
71 | IKBKB | 0.79469701 |
72 | PDPK1 | 0.78440137 |
73 | HIPK2 | 0.76077135 |
74 | PRKAA1 | 0.75864256 |
75 | MARK2 | 0.74363770 |
76 | JAK3 | 0.74151988 |
77 | MAP3K7 | 0.73235794 |
78 | ABL2 | 0.72608617 |
79 | SGK223 | 0.70815949 |
80 | SGK494 | 0.70815949 |
81 | RPS6KA2 | 0.69637162 |
82 | PIM2 | 0.69020230 |
83 | CSK | 0.67543219 |
84 | HCK | 0.64456447 |
85 | PIK3CA | 0.63581756 |
86 | IRAK2 | 0.63504903 |
87 | GRK7 | 0.63442658 |
88 | MAPKAPK3 | 0.63354034 |
89 | RPS6KA6 | 0.62389829 |
90 | PBK | 0.61925958 |
91 | PRKCH | 0.61180887 |
92 | MAP3K12 | 0.60988378 |
93 | MAP3K8 | 0.60813797 |
94 | MAP3K6 | 0.59996639 |
95 | STK10 | 0.58825508 |
96 | STK38 | 0.58799716 |
97 | TNK2 | 0.58285943 |
98 | SGK2 | 0.56986343 |
99 | DDR2 | 0.56956195 |
100 | FGR | 0.56027078 |
101 | PKN1 | 0.55746017 |
102 | MTOR | 0.54467558 |
103 | MYLK | 0.54341997 |
104 | PDGFRA | 0.54121211 |
105 | CSF1R | 0.54065389 |
106 | FES | 0.53999734 |
107 | STK24 | 0.53634760 |
108 | CLK1 | 0.53380690 |
109 | MAPK7 | 0.53175728 |
110 | BTK | 0.52926047 |
111 | GRK6 | 0.52638437 |
112 | RPS6KL1 | 0.52637938 |
113 | RPS6KC1 | 0.52637938 |
114 | MAPKAPK2 | 0.51979731 |
115 | MATK | 0.51479859 |
116 | CDK12 | 0.50699882 |
117 | PTK2 | 0.50306471 |
118 | KSR2 | 0.49936482 |
119 | PRKD2 | 0.49843111 |
120 | MAP2K2 | 0.49741113 |
121 | LMTK2 | 0.49678817 |
122 | OXSR1 | 0.49180218 |
123 | SIK3 | 0.48686561 |
124 | LRRK2 | 0.48353022 |
125 | FGFR3 | 0.48026506 |
126 | PRKD1 | 0.47219125 |
127 | MUSK | 0.46009415 |
128 | PDK1 | 0.45498413 |
129 | ZAP70 | 0.45301688 |
130 | MAP4K1 | 0.45158459 |
131 | DAPK3 | 0.44575647 |
132 | EPHA3 | 0.43915705 |
133 | STK3 | 0.43449235 |
134 | MAP3K11 | 0.42564074 |
135 | MAP3K2 | 0.39888199 |
136 | KIT | 0.39528540 |
137 | MARK3 | 0.38426435 |
138 | IRAK1 | 0.37776827 |
139 | SYK | 0.37412632 |
140 | RIPK1 | 0.36165485 |
141 | PRKG2 | 0.35685003 |
142 | PRKACG | 0.35063299 |
143 | CDK6 | 0.34598533 |
144 | MAPK12 | 0.33947957 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.83321042 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.08516936 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.06673250 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.85142450 |
5 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.80370870 |
6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.69154096 |
7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.67227294 |
8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.64837725 |
9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.59494291 |
10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.54461846 |
11 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.53658216 |
12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.43708253 |
13 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.39696998 |
14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.21117592 |
15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.19851412 |
16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.13409157 |
17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.06691820 |
18 | Leishmaniasis_Homo sapiens_hsa05140 | 2.05433726 |
19 | Peroxisome_Homo sapiens_hsa04146 | 2.05329058 |
20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.02378450 |
21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.97993361 |
22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.95580691 |
23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.90581480 |
24 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.81492858 |
25 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.80875110 |
26 | Tuberculosis_Homo sapiens_hsa05152 | 1.80738580 |
27 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.74256602 |
28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.71480570 |
29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.71283425 |
30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.66591886 |
31 | Histidine metabolism_Homo sapiens_hsa00340 | 1.62842947 |
32 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.58198112 |
33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.57037391 |
34 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.55939660 |
35 | Malaria_Homo sapiens_hsa05144 | 1.54873905 |
36 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53382167 |
37 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.52590187 |
38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.52437324 |
39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.52173046 |
40 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.50933606 |
41 | Influenza A_Homo sapiens_hsa05164 | 1.46020799 |
42 | Pertussis_Homo sapiens_hsa05133 | 1.45948983 |
43 | Shigellosis_Homo sapiens_hsa05131 | 1.45857487 |
44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42957155 |
45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.41851772 |
46 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.40500582 |
47 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.38458437 |
48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.38364131 |
49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.38089716 |
50 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37904488 |
51 | Bile secretion_Homo sapiens_hsa04976 | 1.37607206 |
52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.37027917 |
53 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.34901104 |
54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.34233414 |
55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.33334258 |
56 | Apoptosis_Homo sapiens_hsa04210 | 1.32924086 |
57 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.32786853 |
58 | Retinol metabolism_Homo sapiens_hsa00830 | 1.32082214 |
59 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.31028991 |
60 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.29271798 |
61 | Hepatitis B_Homo sapiens_hsa05161 | 1.25381456 |
62 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.24319675 |
63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.23386107 |
64 | Phagosome_Homo sapiens_hsa04145 | 1.23242472 |
65 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.20957186 |
66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20709563 |
67 | Salmonella infection_Homo sapiens_hsa05132 | 1.19720139 |
68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.19395402 |
69 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19143731 |
70 | ABC transporters_Homo sapiens_hsa02010 | 1.17722768 |
71 | Allograft rejection_Homo sapiens_hsa05330 | 1.17404149 |
72 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.16621310 |
73 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.16291830 |
74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.14588870 |
75 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.13194962 |
76 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.13088204 |
77 | Measles_Homo sapiens_hsa05162 | 1.13048503 |
78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.11201988 |
79 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09502659 |
80 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.08599813 |
81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.07935935 |
82 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.06864451 |
83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.04435735 |
84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.04118107 |
85 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.02355211 |
86 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.01508232 |
87 | Viral myocarditis_Homo sapiens_hsa05416 | 1.00849998 |
88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.99470426 |
89 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.98269907 |
90 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97846261 |
91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.97614595 |
92 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.97343581 |
93 | Lysine degradation_Homo sapiens_hsa00310 | 0.96316212 |
94 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.95998943 |
95 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.95967816 |
96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93721652 |
97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.93682136 |
98 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.92740754 |
99 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.92095741 |
100 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.91326161 |
101 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.91196616 |
102 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89501310 |
103 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.87827701 |
104 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87777967 |
105 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87656440 |
106 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.86676277 |
107 | Endocytosis_Homo sapiens_hsa04144 | 0.86625838 |
108 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.85974388 |
109 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.85416410 |
110 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84504838 |
111 | Sulfur relay system_Homo sapiens_hsa04122 | 0.83258445 |
112 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81215197 |
113 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.78368025 |
114 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.76616386 |
115 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.74958917 |
116 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.74671388 |
117 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74605650 |
118 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.73201539 |
119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71824863 |
120 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.68910649 |
121 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.66978569 |
122 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64518360 |
123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.63472150 |
124 | Asthma_Homo sapiens_hsa05310 | 0.61993912 |
125 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61763629 |
126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60463367 |
127 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60140072 |
128 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.60126408 |
129 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.57798336 |
130 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.56420127 |
131 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56350371 |
132 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56026317 |
133 | Endometrial cancer_Homo sapiens_hsa05213 | 0.55262568 |
134 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55166433 |
135 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52410516 |
136 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.52384785 |
137 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51973482 |
138 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.50804975 |
139 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50160027 |
140 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48543912 |
141 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48537544 |
142 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.47629072 |
143 | Insulin resistance_Homo sapiens_hsa04931 | 0.47578754 |
144 | Prostate cancer_Homo sapiens_hsa05215 | 0.45965326 |
145 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.45798168 |
146 | Metabolic pathways_Homo sapiens_hsa01100 | 0.44167063 |
147 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.44038879 |
148 | Focal adhesion_Homo sapiens_hsa04510 | 0.43510731 |
149 | Prion diseases_Homo sapiens_hsa05020 | 0.39639112 |
150 | Lysosome_Homo sapiens_hsa04142 | 0.31421170 |
151 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.24378057 |
152 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19242667 |
153 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.19071906 |
154 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.18948507 |
155 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.17930091 |
156 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.17393707 |
157 | Other glycan degradation_Homo sapiens_hsa00511 | 0.15873057 |
158 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.11269477 |
159 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10955287 |
160 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.10919369 |
161 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09145894 |
162 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.06215032 |
163 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.06123043 |
164 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.06053010 |
165 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.04591170 |
166 | Bladder cancer_Homo sapiens_hsa05219 | 0.04439729 |
167 | Amoebiasis_Homo sapiens_hsa05146 | 0.04375679 |
168 | Hepatitis C_Homo sapiens_hsa05160 | 0.03567755 |
169 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.02869393 |
170 | Legionellosis_Homo sapiens_hsa05134 | 0.02527119 |
171 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.02215194 |
172 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.00434528 |
173 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.00246386 |
174 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0263583 |
175 | Acute myeloid leukemia_Homo sapiens_hsa05221 | -0.0186283 |